BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25471640)

  • 21. Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia.
    Bonnet M; San KC; Pho Y; Sok C; Dousset JP; Brant W; Hurtado N; Eam KK; Ardizzoni E; Heng S; Godreuil S; Yew WW; Hewison C
    Emerg Infect Dis; 2017 Jul; 23(7):1139-1147. PubMed ID: 28628437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Bassett IV
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):274-80. PubMed ID: 25415288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
    Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
    BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.
    Zijenah LS; Kadzirange G; Bandason T; Chipiti MM; Gwambiwa B; Makoga F; Chungu P; Kaguru P; Dheda K
    BMC Infect Dis; 2016 Jan; 16():20. PubMed ID: 26797499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF).
    Viviani L; Harrison MJ; Zolin A; Haworth CS; Floto RA
    J Cyst Fibros; 2016 Sep; 15(5):619-23. PubMed ID: 27050794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis.
    Boehme C; Molokova E; Minja F; Geis S; Loscher T; Maboko L; Koulchin V; Hoelscher M
    Trans R Soc Trop Med Hyg; 2005 Dec; 99(12):893-900. PubMed ID: 16139316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.
    Wang MS; Wang JL; Wang XF
    BMC Pulm Med; 2016 Nov; 16(1):163. PubMed ID: 27887611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of mycobacterial lipoarabinomannan-specific monoclonal antibodies and their ability to identify mycobacterium isolates.
    Yan ZH; Zhao B; Pang Y; Wang XJ; Yi L; Wang HL; Yang B; Wei PJ; Jia HY; Li SP; Zhao YL; Zhang HT
    J Microbiol Immunol Infect; 2021 Jun; 54(3):437-446. PubMed ID: 32146163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Interferon-Gamma Release Assay in Patients with Non-Tuberculous Mycobacteria Pulmonary Disease.
    Jia H; Pan L; Wang G; Duan H; Song Z; Sun Q; Wei R; Du B; Xing A; Zhang Z
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.
    Nakiyingi L; Moodley VM; Manabe YC; Nicol MP; Holshouser M; Armstrong DT; Zemanay W; Sikhondze W; Mbabazi O; Nonyane BA; Shah M; Joloba ML; Alland D; Ellner JJ; Dorman SE
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):270-9. PubMed ID: 24675585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network.
    Suwanpimolkul G; Kawkitinarong K; Manosuthi W; Sophonphan J; Gatechompol S; Ohata PJ; Ubolyam S; Iampornsin T; Katerattanakul P; Avihingsanon A; Ruxrungtham K
    Int J Infect Dis; 2017 Jun; 59():96-102. PubMed ID: 28457751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The frequency and related factors of non-tuberculosis mycobacteria infections among patients with cystic fibrosis.
    Ademhan Tural D; Emiralioglu N; Ozsezen B; Saribas Z; Ozcan N; Alp A; Sunman B; Hizal M; Eryilmaz Polat S; Yalcin E; Dogru D; Ozcelik U; Kiper N
    Pediatr Int; 2021 Nov; 63(11):1369-1375. PubMed ID: 33682254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population.
    Qvist T; Pressler T; Thomsen VO; Skov M; Iversen M; Katzenstein TL
    Transplant Proc; 2013; 45(1):342-5. PubMed ID: 23267788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
    Martiniano SL; Sontag MK; Daley CL; Nick JA; Sagel SD
    Ann Am Thorac Soc; 2014 Jan; 11(1):36-44. PubMed ID: 24251858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers.
    Low D; Wilson DA; Flume PA
    J Cyst Fibros; 2020 Jul; 19(4):569-574. PubMed ID: 32178969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.
    Bouso JM; Burns JJ; Amin R; Livingston FR; Elidemir O
    Pediatr Pulmonol; 2017 Mar; 52(3):324-330. PubMed ID: 28135043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routinely detected indicators in plasma have a predictive effect on the identification of HIV-infected patients with non-tuberculous mycobacterial and tuberculous infections.
    Cai RT; Yu FX; Tao Z; Qian XQ; Chen J; Lu HZ
    Infect Dis Poverty; 2017 Nov; 6(1):132. PubMed ID: 29092717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing nontuberculous mycobacteria infection in cystic fibrosis.
    Bar-On O; Mussaffi H; Mei-Zahav M; Prais D; Steuer G; Stafler P; Hananya S; Blau H
    J Cyst Fibros; 2015 Jan; 14(1):53-62. PubMed ID: 24917112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis.
    Gounder CR; Kufa T; Wada NI; Mngomezulu V; Charalambous S; Hanifa Y; Fielding K; Grant A; Dorman S; Chaisson RE; Churchyard GJ
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):219-23. PubMed ID: 21765364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and clinical outcomes of nontuberculous mycobacteria in a Brazilian cystic fibrosis reference center.
    Aiello TB; Levy CE; Zaccariotto TR; Paschoal IA; Pereira MC; Nolasco da Silva MT; Ribeiro JD; Ribeiro AF; Toro AADC; Mauch RM
    Pathog Dis; 2018 Jul; 76(5):. PubMed ID: 29846573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.